Getting back to the world of clinical research with Industry Voice! In today's episode, we sit down with Kyla Xue, a managing partner at LSV Capital – a multi-stage investment company from China. Kyla unveils her perspectives on the criteria for selecting portfolio companies, the importance of innovation in biotech and medtechs, and shares insights on how to finance areas like immunology, neuroscience, and synthetic biology.
If you're intrigued by how global life science investments shape our future, this is a must-watch!
